Jones Day, Latham Guide Galenica's $1.5B Relypsa Buy

Jones Day advised Galenica Inc. in a $1.5 billion acquisition of Silicon Valley-based Relypsa Inc., guided by Latham & Watkins LLP, setting up a deal that would give Galenica's Vifor Pharma unit full global...

Already a subscriber? Click here to view full article